Skip to Main Content

Author Details

Luc G T Morris
Memorial Sloan Kettering Cancer Center
2003
246
64
PMIDPaper TitleJournal TitlePublished Year
37249223Loss of Human Leukocyte Antigen and Immune Escape in Head and Neck Cancer.Laryngoscope2024
36257862Surgical management of T1/T2 node-negative papillary thyroid cancer with tall cell histology: Is lobectomy enough?Surgery2023
37529400Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities.Cancer Res Commun2023
37561583Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma.J Clin Invest2023
37620627Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.Nat Med2023
37501404Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.Mol Oncol2023
37824134Risk of Carcinoma in Pleomorphic Adenomas of the Parotid.JAMA Otolaryngol Head Neck Surg2023
37683037Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.Sci Immunol2023
37637595Diagnostic Scrutiny and Patterns of Elevated Cancer Risk: Uncovering Overdiagnosis Through Standardized Incidence Ratios.Cureus2023
35758285Transorbital embolization of cavernous sinus dural arterio-venous malformations with surgical exposure and catheterization of the superior ophthalmic vein.Interv Neuroradiol2023
37419120Patterns of immune equilibrium and escape in indolent and progressing tumors.Cancer Cell2023
37383237Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients.Front Immunol2023
37435097Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment.Oncoimmunology2023
36653435FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling.Sci Rep2023
36915573CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy.Transl Cancer Res2023
36780190Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy.Clin Cancer Res2023
34635506Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy.Mol Cancer Res2022
35551339Cervical Pneumatocele Following Total Thyroidectomy Presenting as an Air Thyrogram.JAMA Otolaryngol Head Neck Surg2022
35797031Association Between Toxic Effects and Survival in Patients With Cancer and Autoimmune Disease Treated With Checkpoint Inhibitor Immunotherapy.JAMA Oncol2022
35731870Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma.Sci Adv2022
35393553Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade.NPJ Precis Oncol2022
35817971Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity.Nat Genet2022
35565392Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma.Cancers (Basel)2022
35681795Mutations in <i>KMT2C</i>, <i>BCOR</i> and <i>KDM5C</i> Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer.Cancers (Basel)2022
36536472Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape.Genome Med2022
36336518Relative Survival With Early-Stage Breast Cancer in Screened and Unscreened Populations.Mayo Clin Proc2022
36178355Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns.Thyroid2022
35867947Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404).J Clin Oncol2022
36326739American Thyroid Association Guidelines and National Trends in Management of Papillary Thyroid Carcinoma.JAMA Otolaryngol Head Neck Surg2022
36055464Leveraging big data of immune checkpoint blockade response identifies novel potential targets.Ann Oncol2022
35880270Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients.Int J Biol Markers2022
36113476Clonal hematopoiesis and differential outcomes after immune checkpoint blockade.Cancer Cell2022
33845656Human Papillomavirus in Patients With Hypopharyngeal Squamous Cell Carcinoma.Otolaryngol Head Neck Surg2022
35226089Outcomes Among Patients With or Without Obesity and With Cancer Following Treatment With Immune Checkpoint Blockade.JAMA Netw Open2022
35305137Cytology-based Cancer Surgery of the Head and Neck (CyCaS-HN): a prospective, randomized, controlled clinical trial.Eur Arch Otorhinolaryngol2022
35292516MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.J Immunother Cancer2022
35259623Young non-smokers with oral cancer: What are we missing and why?Oral Oncol2022
35259039Nodal Metastases in Pediatric and Adult Acinic Cell Carcinoma of the Major Salivary Glands.Otolaryngol Head Neck Surg2022
34762303Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.Cancer2022
34725502Improved prediction of immune checkpoint blockade efficacy across multiple cancer types.Nat Biotechnol2022
32726432Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.J Natl Cancer Inst2021
33851469Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.Head Neck2021
33625877OncoTree: A Cancer Classification System for Precision Oncology.JCO Clin Cancer Inform2021
33599686Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase.JAMA Oncol2021
33868581The role of immune surveillance in malignant transformation of benign salivary gland tumors.Oncotarget2021
33756102Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer.Immunity2021
33586179Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center.Int J Cancer2021
33838880Lymph node metastases in pediatric medullary thyroid carcinoma.Surgery2021
33779556Life Expectancy and Treatment Patterns in Elderly Patients With Low-Risk Papillary Thyroid Cancer: A Population-Based Analysis.Endocr Pract2021
33834176Mutations in <i>BRCA1</i> and <i>BRCA2</i> differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy.Nat Cancer2021
  • 1 - 50 of 246

Recommended Authors

Dipti P Sajed
David Geffen School of Medicine University of California Los Angeles California USA.
Career Start Year 2016
Number of shared co-authors 6
Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 14
Neil Mundi
Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 14
Ryan K Orosco
university of california san diego
Career Start Year 2010
Number of shared co-authors 2
John Pang
University of Washington
Career Start Year 2009
Number of shared co-authors 4
Keith Kwan
Western University
Career Start Year 2009
Number of shared co-authors 12
Ryan Li
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 9
Farhoud Faraji
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 3
Jennifer R Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 9
Laveniya Satgunaseelan
Royal Prince Alfred Hospital
Career Start Year 2007
Number of shared co-authors 2
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 11
Mizuo Ando
University of Tokyo
Career Start Year 2005
Number of shared co-authors 3
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 9
Kathrin Scheckenbach
Heinrich-Heine University
Career Start Year 2002
Number of shared co-authors 15
Akihiro Sakai
Tokai University
Career Start Year 2002
Number of shared co-authors 3
Michelle D Williams
The University of Texas M. D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 6
Ezra E W Cohen
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 15
Dexiang Gao
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 0
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 9
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 22
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 6
Mark W Lingen
University of Chicago Pritzker School of Medicine
Career Start Year 1993
Number of shared co-authors 5
Joseph C Dort
Cumming School of Medicine, University of Calgary
Career Start Year 1990
Number of shared co-authors 15
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 16
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 21
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 24
Wayne M Koch
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 10
Michael P Hier
Jewish General Hospital, McGill University
Career Start Year 1987
Number of shared co-authors 15
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 5
Joseph A Califano
University of California
Career Start Year 1977
Number of shared co-authors 11

Collaborators

Timothy A Chan
Cleveland Clinic.
Co-authored papers 53
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Co-authored papers 41
Richard J Wong
Memorial Sloan Kettering Cancer Center
Co-authored papers 39
Nancy Y Lee
Memorial Sloan Kettering Cancer Center
Co-authored papers 29
Fengshen Kuo
Memorial Sloan Kettering Cancer Center
Co-authored papers 22
Nora Katabi
Memorial Sloan Kettering Cancer Center
Co-authored papers 20
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Co-authored papers 20
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Co-authored papers 19
Alan L Ho
Memorial Sloan Kettering Cancer Center
Co-authored papers 19
Sean M McBride
Memorial Sloan Kettering Cancer Center
Co-authored papers 15
David G Pfister
Memorial Sloan Kettering Cancer Center
Co-authored papers 14
Bhuvanesh Singh
Memorial Sloan Kettering Cancer Center
Co-authored papers 14
Michael F Berger
Co-authored papers 13
Jay O Boyle
Memorial Sloan Kettering Cancer Center
Co-authored papers 13
Andrew G Sikora
Co-authored papers 12
Mark Lee
Memorial Sloan Kettering Cancer Center (MSKCC)
Co-authored papers 11
Abraham Ari Hakimi
Co-authored papers 11
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 9
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Mithat Gonen
Co-authored papers 6
José Baselga
Co-authored papers 5
Simon N Powell
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Agnes Viale
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Xin Pei
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Benjamin E Gross
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Release 1.2